Kayne Anderson Rudnick Investment Management
INSM icon

Kayne Anderson Rudnick Investment Management’s Insmed INSM Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-115
Closed -$3K – 643
2022
Q1 		$3K Buy
+115
New +$2.67K ﹤0.01% 581

Other funds holding INSM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's INSM Position: Q2 2022 in Review

Kayne Anderson Rudnick Investment Management sold out of Insmed (INSM) in Q2 2022, closing a stake of 115 shares — an estimated $3K sold.

Kayne Anderson Rudnick Investment Management first reported a position in INSM in Q1 2022 and held it in 1 quarter. The position peaked at $3K in Q1 2022. 214 funds tracked by Wall St. Rank hold INSM as of Q2 2022.

  • Kayne Anderson Rudnick Investment Management reported no remaining Insmed position as of Q2 2022 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 115 Insmed shares in Q2 2022, an estimated $3K.
  • Kayne Anderson Rudnick Investment Management first reported a position in Insmed in Q1 2022 and held it in 1 quarter.
  • Kayne Anderson Rudnick Investment Management's Insmed position peaked at $3K in Q1 2022.
  • 214 funds tracked by Wall St. Rank held Insmed as of Q2 2022.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2022, filed 12 Aug 2022.